Updates from The Motley Fool

Latest updates on Kite Pharma from
CAR-T Stocks: Time to Panic?

Image source: Getty Images. What: Shares of the chimeric antigen receptor (CAR) transduced T cel...

3 Biotech Stocks to Buy in July

Image source: Getty Images. It's been a rough year to be a biotech investor. The market-cap-weigh...

7 Stocks to Buy in June

June is here, and you might be readying yourself for an onslaught of warm-weather activities. But...

Stock Performance

View Interactive KITE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Kite Pharma.
Current Price: $44.01
Prev Close: $45.68
Open: $46.11
Bid: $43.85
Ask: $44.50
Day's Range: $43.82 - $46.51
52wk Range: $38.41 - $89.84
Volume: 933,897
Avg Vol 1,195,798
Market Cap: $2B
P/E (ttm): -12.35
EPS (ttm): ($3.70)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Kite Pharma.
CAPS Rating 4 out of 5
106 Outperform
11 Underperform
CAPS All Stars
33 Outperform
3 Underperform

How do you think Kite Pharma will perform against the market?

You pick for Kite Pharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Kite Pharma.


  • Exchange: NASDAQ